LIVN
HealthcareLivaNova PLC
$63.23
+$2.59 (+4.27%)
Jan 5, 2026
Price History (1Y)
Analysis
LivaNova PLC is a healthcare company operating in the medical devices industry. The company's scale is significant, with a market capitalization of $3.45B and revenue of $1.35B (TTM). It has a substantial workforce, employing approximately 2900 individuals. Financially, LivaNova PLC reports mixed results. Its profitability is affected by a negative profit margin of -16.1%, while its gross and operating margins are higher at 69.4% and 16.5%, respectively. The company's returns on equity and assets stand at -17.6% and 5.2%, respectively, indicating a significant decline in net income (TTM: -$217,486,000). Its balance sheet shows $486.55M in debt and $646.08M in cash. LivaNova PLC's valuation metrics are as follows: its forward P/E ratio is 15.28, and its price to book is 2.98. The company's revenue growth rate is 12.5% (YoY), while earnings growth is -18.3% (YoY).
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About LivaNova PLC
LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products and therapies for neurological and cardiac conditions worldwide. The company operates in two segments, Cardiopulmonary and Neuromodulation. The Cardiopulmonary segment provides cardiopulmonary products, including heart-lung machines, oxygenators, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related accessories. The Neuromodulation segment offers VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; and devices that deliver neuromodulation therapy for treating difficult-to-treat depression and drug-resistant epilepsy. The company serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its medical devices through a combination of direct sales representatives, agents, and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.
Visit website →Key Statistics
- Market Cap
- $3.45B
- P/E Ratio
- N/A
- 52-Week High
- $65.57
- 52-Week Low
- $32.48
- Avg Volume
- 559.21K
- Beta
- 0.97
Company Info
- Industry
- Medical Devices
- Exchange
- NMS
- Country
- United Kingdom
- Employees
- 2,900